Clinical Trial

Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Mechanically ventilated intensive care patients will be sampled for a small amount of exhaled breath condensate from the ventilator circuit and for venous blood. Proteomic analysis of the exhaled breath condensate will be performed using mass spectrometry and in the blood sample, corresponding changes in the DNA, RNA, proteins, and metabolites will be studied. Resulting profiles will be correlated with routinely monitored parameters in order to identify patterns corresponding to various pathologies in order to enable their early detection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-02; most recent amendment 2026-06-23.
Status change: Not Yet Recruiting → Recruiting 2026-03-19
Trial Details
NCT Number NCT06189924
Lead Sponsor The Institute of Molecular and Translational Medicine, Czech Republic
Conditions Acute Respiratory Failure, Critical Illness
Enrollment 200 participants
Start Date 2026-03-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25